Suppr超能文献

高血压对活体供肾者肾功能及肾活检的影响。

Renal function outcomes and kidney biopsy features of living kidney donors with hypertension.

机构信息

Division of Nephrology & Hypertension, Mayo Clinic, Rochester, MN, USA.

William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USA.

出版信息

Clin Transplant. 2021 Jun;35(6):e14293. doi: 10.1111/ctr.14293. Epub 2021 Mar 30.

Abstract

BACKGROUND

The medium- to long-term outcomes of living kidney donors with hypertension compared to normotensive donors are not well understood, especially with the recent changes in hypertension guidelines.

METHODS

We studied a cohort of 950 living kidney donors using different definitions of hypertension based on either ≥140/90 or ≥130/80 mmHg thresholds and based on either office or ambulatory blood pressure readings. Microstructural features on kidney biopsy at the time of donation were compared using different definitions of hypertension.

RESULTS

After adjusting for years of follow-up, age, sex, and baseline eGFR, hypertension (by any definition) did not significantly predict an eGFR < 45 ml/min/1.73 m at a median follow-up of 10 years postdonation, though there was a borderline association with ambulatory blood pressure ≥ 130/80 mmHg predicting a 40% decline in eGFR (OR = 1.53, 1.00-2.36; p = .051). Proteinuria was predicted by office blood pressure ≥ 140/90 mmHg and by nondipper profile on nocturnal ambulatory blood pressure measurements. At the time of donation, larger glomeruli and arterial hyalinosis on biopsy were associated with hypertension defined by either ≥140/90 or ≥130/80 mmHg (by office or ambulatory measurements). Nocturnal nondipper status was associated with larger glomeruli size but not arteriolar hyalinosis when compared to dippers.

CONCLUSIONS

In programs that accept donors with controlled hypertension, various definitions of hypertension are associated with histological findings in the donated kidney, but none predict a clinically significant decline in kidney function 10 years after donation. These data support allowing healthy individuals with controlled hypertension to donate a kidney. However, donors with office hypertension (≥140/90 mmHg) and nondippers (regardless of hypertension status) are at greater long-term risk for proteinuria, and particularly for these donors, longer follow-up is warranted.

摘要

背景

与血压正常的供体相比,患有高血压的活体肾脏供体的中-长期预后尚不清楚,尤其是在高血压指南最近发生变化的情况下。

方法

我们根据≥140/90 或≥130/80mmHg 阈值和诊室或动态血压读数,使用不同的高血压定义,对 950 名活体肾脏供体进行了研究。根据不同的高血压定义,比较了供体时肾脏活检的微观结构特征。

结果

在校正随访年限、年龄、性别和基线 eGFR 后,任何定义的高血压(均未)显著预测捐赠后中位 10 年的 eGFR<45ml/min/1.73m,尽管动态血压监测≥130/80mmHg 与 eGFR 下降 40%存在边缘关联(OR=1.53,1.00-2.36;p=0.051)。蛋白尿与诊室血压≥140/90mmHg 和夜间动态血压测量的非杓型有关。在供体时,活检中较大的肾小球和动脉玻璃样变性与≥140/90 或≥130/80mmHg 定义的高血压(通过诊室或动态测量)相关。与夜间杓型相比,非杓型状态与更大的肾小球体积有关,但与小动脉玻璃样变性无关。

结论

在接受控制良好的高血压供体的项目中,各种高血压定义与供体肾脏的组织学发现相关,但没有一种定义能预测捐赠后 10 年肾功能出现临床显著下降。这些数据支持允许健康的高血压患者捐献肾脏。然而,有诊室高血压(≥140/90mmHg)和非杓型的供体(无论高血压状态如何)蛋白尿的长期风险更高,特别是对于这些供体,需要更长时间的随访。

相似文献

7
A prospective controlled study of living kidney donors: three-year follow-up.活体肾供体的前瞻性对照研究:三年随访
Am J Kidney Dis. 2015 Jul;66(1):114-24. doi: 10.1053/j.ajkd.2015.01.019. Epub 2015 Mar 17.

本文引用的文献

3
OPTN/SRTR 2018 Annual Data Report: Kidney.OPTN/SRTR 2018 年度数据报告:肾脏。
Am J Transplant. 2020 Jan;20 Suppl s1:20-130. doi: 10.1111/ajt.15672.
4
Risk of ESKD in Older Live Kidney Donors with Hypertension.患有高血压的老年活体肾供者发生终末期肾病的风险
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1048-1055. doi: 10.2215/CJN.14031118. Epub 2019 Jun 25.
10
The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging.健康人肾脏中肾单位随衰老而大量丧失。
J Am Soc Nephrol. 2017 Jan;28(1):313-320. doi: 10.1681/ASN.2016020154. Epub 2016 Jul 8.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验